Skip to main content

Table 3 Surgical outcomes and postoperative courses of the 52 enrolled patients

From: Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy

Variable

All patients (n = 52)

NAC (n = 20)

Non-NAC (n = 32)

P

Operative time (min, mean ± SD)

276.3 ± 60.1

245.5 ± 59.1

289.4 ± 63.4

0.082

Intraoperative blood loss (mL, mean ± SD)

104.3± 111.1

115.0 ± 111.3

100.8 ± 111.0

0.661

Postoperative complication (Grades 3–4)

18 (34.6)

8 (40.0)

10 (31.3)

0.519

 Arrhythmia

1 (1.9)

1 (5.0)

0 (0)

 

 Pneumonia

3 (5.8)

2 (10.0)

1 (3.1)

 

 Anastomotic leakage

3 (5.8)

1 (5.0)

2 (6.3)

 

 Ileus

7 (13.5)

3 (15.0)

4 (12.5)

 

 Abdominal abscess

3 (5.8)

1 (5.0)

2 (6.3)

 

 Intra-abdominal haemorrhage

1 (1.9)

0 (0)

1 (3.1)

 

 Wound infection

5 (9.6)

2 (10.0)

3 (9.4)

 

Toxicity indexes after HIPEC

22 (42.3)

10 (50.0)

12 (37.5)

0.375

 Abnormal changes in neutrophils

6 (11.5)

3 (15.0)

3 (9.4)

0.864

 Abnormal changes in platelets

8 (15.4)

6 (30.0)

2 (6.3)

0.043

 Abnormal changes in ALT

8 (15.4)

2 (10.0)

6 (18.8)

0.463

 Abnormal changes in creatinine

3 (5.8)

1 (5.0)

2 (6.3)

1.000

Time to first flatus (day, mean ± SD)

3.8 ± 1.8

4.1 ± 1.9

3.6 ± 1.8

0.811

Total hospital stay (day, mean ± SD)

14.4 ± 5.0

15.4 ± 6.0

13.9 ± 3.9

0.333

Re-operation

1 (1.9)

1 (5.0)

0 (0)

1.000

Mortality (%)

0 (0)

0 (0)

0 (0)

1.000